United Therapeutics Corporation
USD540.05
-4.57 (-0.84%)
CEO
Martine A. Rothblatt
IPO Date
1999-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$537.56
Prev. Close
$544.62
Day Low
$534.97
Day High
$544.91
52W Low
$272.12
52W High
$609.35
Market Cap
$22.92B
Volume
0.37M
| 1,000 |
| $555.59 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 461 | $556.67 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 918 | $557.80 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 841 | $558.81 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 320 | $559.41 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | M-Exempt | Disposed | 9,500 | $146.03 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | M-Exempt | Acquired | 9,500 | $146.03 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 280 | $548.60 |
| 1 Jun 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | S-Sale | Disposed | 769 | $549.59 |
| 18 Apr 2022 | Michael McCaul | Michael McCaul | Purchase | $15,001 - $50,000 |
| 18 Apr 2022 | Michael McCaul | Michael McCaul | Purchase | $1,001 - $15,000 |
| 23 Feb 2022 | Michael McCaul | Michael McCaul | Sale | $1,001 - $15,000 |
| 23 Feb 2022 | Michael McCaul | Michael McCaul | Sale | $15,001 - $50,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Sale (Full) | $1,001 - $15,000 |